Fusion Pharmaceuticals Inc. - stock earnings
FUSN Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -17.3 million USD | 2.0 million USD |
| 2023Q2 | -25.2 million USD | 34000 USD |
| 2023Q1 | -24.3 million USD | 28000 USD |
| 2022Q4 | -24.6 million USD | 140000 USD |
| 2022Q3 | -24.0 million USD | 166000 USD |
| 2022Q2 | -19.1 million USD | 570000 USD |
| 2022Q1 | -19.9 million USD | 585000 USD |
| 2021Q4 | -17.2 million USD | 594000 USD |
| 2021Q3 | -19.4 million USD | 325000 USD |
| 2021Q2 | -26.9 million USD | 521000 USD |
| 2021Q1 | -17.5 million USD | ? USD |
| 2020Q4 | -13.4 million USD | ? USD |
| 2020Q3 | -10.0 million USD | ? USD |
| 2020Q2 | -44.7 million USD | ? USD |
| 2020Q1 | -10.2 million USD | ? USD |
| 2019Q4 | -8.2 million USD | ? USD |
| 2019Q3 | -594000 USD | ? USD |
| 2019Q2 | -3.5 million USD | ? USD |
| 2019Q1 | -3.9 million USD | ? USD |
| 2000Q3 | ? USD | 106000 USD |
FUSN Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -91.3 million USD | 2.2 million USD |
| 2022 | -87.6 million USD | 1.5 million USD |
| 2021 | -81.0 million USD | 1.4 million USD |
| 2020 | -78.3 million USD | 521000 USD |
| 2019 | -16.2 million USD | ? USD |
| 2018 | -11.7 million USD | ? USD |
| 2017 | -6.3 million USD | ? USD |
FUSN
Price: $21.45
52 week price:
Earnings Per Share: -1.45 USD
P/E Ratio: -6.94
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 14300
Market Capitalization: 1.8 billion